26

2016

-

07

National Autoimmune Disease Diagnostic Technology National Promotion Course-Guangxi Liuzhou Station

On July 23, 2016, the fifth stop of the national promotion class of autoimmune disease diagnosis technology was held in Liuzhou, Guangxi, a beautiful tourist city. More than 200 relevant personnel from various hospital laboratories in Guangxi, Guangdong and Guizhou provinces attended the training conference.


Author:

On July 23, 2016, the fifth stop of the national promotion class of autoimmune disease diagnosis technology was held in Liuzhou, Guangxi, a beautiful tourist city. More than 200 relevant personnel from various hospital laboratories in Guangxi, Guangdong and Guizhou provinces attended the training conference.

 

IMG_256

 

The chairman of the conference and director Dai Shengming of Liuzhou Workers' Hospital introduced the participating experts and solemnly invited Professor Li Yongzhe, vice chairman of the Laboratory Medicine Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine, to give a speech and give a special lecture. Professor Li emphasized in the special report "New Progress in Autoimmune Disease Experimental Diagnosis Technology" that the strong combination of multi-indicator joint detection and chemiluminescence mainstream methodology of microfluidic technology platform is a huge impact on the traditional test mode and the existing test mode.

 

IMG_257

 

Beijing Nano-Ace Technology Co., Ltd. was invited to participate in this conference. The Nano-Ace staff gave a special explanation on microfluidic technology. The guests on the scene responded enthusiastically. The Nano-Ace microfluidic products received more and more attention and became more and more popular.

 

IMG_258

IMG_259

 

During the tea break of the meeting, there was an endless stream of guests who came to consult the microfluidic technology platform and products, and the publicity of the meeting had a very obvious effect.

Beijing Nano-Ace Technology Co., Ltd. by virtue of the patent advantages of microfluidic technology platform, as a new rising star in the field of IVD has been more and more attention and recognition by the industry. Beijing Nano-Ace will continue to forge ahead in the IVD industry, the pursuit of excellence, is committed to the cause of human health. Looking forward to win-win cooperation with you!